Trials / Conditions / Inherited Metabolic Disorders (IMD)
Inherited Metabolic Disorders (IMD)
5 registered clinical trials studyying Inherited Metabolic Disorders (IMD) — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC NCT04528355 | Paul Szabolcs | — |
| Terminated | A Follow-up Study in Patients With Inherited Metabolic Disorders (IMD) Who Underwent Hematopoietic Stem Cell T NCT04008849 | Magenta Therapeutics, Inc. | — |
| Completed | MGTA-456 in Patients With Inherited Metabolic Disorders Undergoing Hematopoietic Stem Cell Transplantation (HS NCT03406962 | Magenta Therapeutics, Inc. | Phase 2 |
| Withdrawn | Safety and Exploratory Efficacy of HSC835 in Patients With Inherited Metabolic Disorders (IMD) NCT02715505 | Novartis Pharmaceuticals | Phase 1 / Phase 2 |
| Recruiting | Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT NCT01962415 | Paul Szabolcs | Phase 2 |